Literature DB >> 11856815

TGF-beta1 is an autocrine mediator of renal tubular epithelial cell growth and collagen IV production.

Joseph P Grande1, Gina M Warner, Henry J Walker, Ahad N K Yusufi, Jingfei Cheng, Catherine E Gray, Jeffrey B Kopp, Karl A Nath.   

Abstract

Recent studies in cultured cells have provided evidence that a variety of pathobiologic stimuli, including high glucose, angiotensin II, and thromboxane A(2), trigger a signaling pathway leading to autocrine induction of TGF-beta1. TGF-beta1 production through this pathway may profoundly affect cell growth, matrix synthesis, and response to injury. This study examines the role of autocrine versus exogenously added TGF-beta1 in cellular proliferation and collagen IV production, critical targets of TGF-beta1 signaling, using renal cells derived from TGF-beta1 knockout (KO) animals or wild-type (WT) controls. Growth of WT and KO cells was assessed by cell counting and [(3)H]thymidine uptake. Basal and TGF-beta1-stimulated collagen production was assessed by Northern and Western blotting; transcriptional activity of the alpha1(IV) collagen gene was assessed by transient transfection analysis. KO cells grew at a faster rate than WT cells carefully matched for plating density and passage number. This increased growth rate was paralleled by increases in [(3)H]thymidine uptake. KO cells expressed lower levels of the cell cycle inhibitors p21 and p27 than WT cells. KO cells failed to express TGF-beta1, as expected. Basal TGF-beta3 mRNA levels were higher in KO cells than in WT cells. WT cells expressed higher basal levels of TGF-beta2 mRNA than KO cells. Basal alpha1(IV) and alpha2(IV) collagen mRNA and protein expression were significantly lower in KO cells than WT cells. Administration of exogenous TGF-beta1 induced collagen IV production in both KO and WT cells. Although basal transcriptional activity of an alpha1(IV) collagen-CAT construct was lower in KO cells than WT cells, administration of exogenous TGF-beta1 was associated with significant increases in transcriptional activity of this construct in both KO and WT cells. These studies provide evidence that autocrine production of TGF-beta1 may play a critical role in regulation of growth and basal collagen IV production by renal tubular epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856815     DOI: 10.1177/153537020222700304

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  13 in total

1.  Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.

Authors:  Shreyas Das; Bryan N Becker; F Michael Hoffmann; Janet E Mertz
Journal:  BMC Cell Biol       Date:  2009-12-21       Impact factor: 4.241

2.  Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension.

Authors:  Gina M Warner; Jingfei Cheng; Bruce E Knudsen; Catherine E Gray; Ansgar Deibel; Justin E Juskewitch; Lilach O Lerman; Stephen C Textor; Karl A Nath; Joseph P Grande
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-29

3.  Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.

Authors:  Ching-Fang Wu; Wen-Chih Chiang; Chun-Fu Lai; Fan-Chi Chang; Yi-Ting Chen; Yu-Hsiang Chou; Ting-Hui Wu; Geoffrey R Linn; Hong Ling; Kwan-Dun Wu; Tun-Jun Tsai; Yung-Ming Chen; Jeremy S Duffield; Shuei-Liong Lin
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

4.  Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.

Authors:  Minoru Satoh; Hajime Nagasu; Yoshitaka Morita; Terry P Yamaguchi; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

5.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

Authors:  Arthur C K Chung; Haiyan Zhang; Yao-Zhong Kong; Jia-Ju Tan; Xiao R Huang; Jeffrey B Kopp; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

6.  Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

Authors:  A Wimmel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

7.  Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia.

Authors:  Hui Geng; Rongpei Lan; Guichun Wang; Abdur R Siddiqi; Michael C Naski; Andrew I Brooks; Jeffrey L Barnes; Pothana Saikumar; Joel M Weinberg; Manjeri A Venkatachalam
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

Review 8.  Management of renal artery stenosis: What does the experimental evidence tell us?

Authors:  Mohammed Al-Suraih; Joseph Peter Grande
Journal:  World J Cardiol       Date:  2014-08-26

9.  Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.

Authors:  Lin Sun; Dongshan Zhang; Fuyou Liu; Xudong Xiang; Guanghui Ling; Li Xiao; Yinghong Liu; Xuejing Zhu; Ming Zhan; Yeyi Yang; Vinay K Kondeti; Yashpal S Kanwar
Journal:  J Pathol       Date:  2011-08-24       Impact factor: 7.996

10.  Mesenchymal Stem Cells Attenuates TGF-β1-Induced EMT by Increasing HGF Expression in HK-2 Cells.

Authors:  Jun-Jun Wei; Li Tang; Liang-Liang Chen; Zhen-Hua Xie; Yu Ren; Hong-Gang Qi; Jiang-Yong Lou; Guo-Bin Weng; Shu-Wei Zhang
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.